Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: South Korea Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20121
20132
20149
20154
20167
20177
20189
20195
20209
202111
20228
20237
202413
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Active, not recruiting24
Recruiting17
Terminated15
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca12
Novartis Pharmaceuticals10
AbbVie6
Eli Lilly and Company6
Amgen3
Bayer3
Boehringer Ingelheim3
Genentech, Inc.3
MedImmune LLC3
Blueprint Medicines Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung104
Neoplasms37
Colorectal Neoplasms23
Neoplasm Metastasis19
Lung Neoplasms16
Pancreatic Neoplasms13
Squamous Cell Carcinoma of Head and Neck12
Stomach Neoplasms12
Breast Neoplasms10
Melanoma10

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.